Total submissions: 3
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Labcorp Genetics |
RCV001421997 | SCV001624531 | likely benign | Nemaline myopathy 2 | 2024-01-31 | criteria provided, single submitter | clinical testing | |
Natera, |
RCV001421997 | SCV002077713 | likely benign | Nemaline myopathy 2 | 2020-05-02 | no assertion criteria provided | clinical testing | |
Prevention |
RCV004738290 | SCV005362007 | likely benign | NEB-related disorder | 2019-04-10 | no assertion criteria provided | clinical testing | This variant is classified as likely benign based on ACMG/AMP sequence variant interpretation guidelines (Richards et al. 2015 PMID: 25741868, with internal and published modifications). |